Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
March 03, 2023 08:00 ET
|
Daxor Corporation
Oak Ridge, TN, March 03, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today issued a corporate update in a Letter to...
Daxor Corporation Reports a 37% Increase in NAV to $6.75 Per Share for the Year Ended December 31, 2022
March 02, 2023 07:00 ET
|
Daxor Corporation
Conference Call to be held today at 9:00 AM EST Oak Ridge, TN, March 02, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, filed...
Daxor Corporation to Report Fiscal Year 2022 Financial Results on Wednesday, March 1, 2023 and Provide Corporate Update
March 01, 2023 08:00 ET
|
Daxor Corporation
Conference Call to be held at 9 AM EST March 2, 2023 Oak Ridge, TN, March 01, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology,...
Daxor Corporation Appoints Linda Cooper, Vice President Project Management
February 17, 2023 08:00 ET
|
Daxor Corporation
Oak Ridge, TN, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the appointment of Linda Cooper as Vice...
Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member
January 19, 2023 08:00 ET
|
Daxor Corporation
Oak Ridge, TN, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces joining the Heart Failure Society of...
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress
January 13, 2023 08:00 ET
|
Daxor Corporation
Oak Ridge, TN, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be presenting at the Society for...
Newly Published Study Proves Value and Clinical Benefit of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Evaluation of Heart Failure
January 03, 2023 08:00 ET
|
Daxor Corporation
Study Shows Direct Volume Measurement’s Accuracy Compared to Pressure Measures Oak Ridge, TN, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...
Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
November 17, 2022 11:07 ET
|
Daxor Corporation
Oak Ridge, TN, Nov. 17, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the closing of...
Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering
November 15, 2022 08:45 ET
|
Daxor Corporation
Oak Ridge, TN, Nov. 15, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the pricing of...
Daxor Corporation Announces Launch of Proposed Underwritten Public Offering
November 14, 2022 17:03 ET
|
Daxor Corporation
Oak Ridge, TN, Nov. 14, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced that it has...